Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes
Nakar C, Thibaudeau K, Mathias M, McDaniel H, Reschke M, Tenbrock K, Parker JM, Shapiro A
Plain Language Summary:
Type 1 plasminogen deficiency (PLGD-1) is an ultra-rare genetic disorder that can cause fibrin-rich lesions throughout the body, sometimes leading to serious complications in children. In this study, treatment with intravenous plasminogen concentrate raised plasminogen levels and helped resolve lesions in multiple organs and tissues. The findings show that this targeted therapy addresses the underlying cause of the disease and highlight the importance of early diagnosis and prompt treatment to prevent long-term health problems.
